Back
Acumen Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
75
ABOS
Acumen Pharmaceuticals, Inc.
Last Price:
$2.57
Seasonality Move:
-13.66%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and ABOS is experiencing selling pressure, which indicates risk of future bearish movement.
Acumen Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.54 | Buy |
| 20-day SMA: | 2.5 | Buy |
| 50-day SMA: | 2.19 | Buy |
| 200-day SMA: | 1.67 | Buy |
| 8-day EMA: | 2.55 | Buy |
| 20-day EMA: | 2.44 | Buy |
| 50-day EMA: | 2.24 | Buy |
| 200-day EMA: | 1.9 | Buy |
Acumen Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 56.63 | Buy |
| Chaikin Money Flow: | -188932 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.07 - 2.69) | Buy |
| Bollinger Bands (100): | (1.78 - 2.36) | Buy |
Acumen Pharmaceuticals, Inc. Technical Analysis
| Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Acumen Pharmaceuticals, Inc. Stock
Is Acumen Pharmaceuticals, Inc. Stock a Buy?
-
Acumen Pharmaceuticals, Inc. share price is 2.57 while ABOS 8-day simple moving average is 2.54, which is a Buy signal.
-
The stock price of ABOS is 2.57 while Acumen Pharmaceuticals, Inc. 20-day SMA is 2.50, which makes it a Buy.
-
Acumen Pharmaceuticals, Inc. 50-day simple moving average is 2.19 while ABOS share price is 2.57, making it a Buy technically.
-
ABOS stock price is 2.57 and Acumen Pharmaceuticals, Inc. 200-day simple moving average is 1.67, creating a Buy signal.
ABOS Technical Analysis vs Fundamental Analysis
Buy
75
Acumen Pharmaceuticals, Inc. (ABOS)
is a Buy
Is Acumen Pharmaceuticals, Inc. a Buy or a Sell?
-
Acumen Pharmaceuticals, Inc. stock is rated a BuyThe current Acumen Pharmaceuticals, Inc. [ABOS] share price is $2.57. The Score for ABOS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
Acumen Pharmaceuticals, Inc. Stock Info
Market Cap:
155.7M
Price in USD:
2.57
Share Volume:
221.5K
Acumen Pharmaceuticals, Inc. 52-Week Range
52-Week High:
3.05
52-Week Low:
0.86
Buy
75
Acumen Pharmaceuticals, Inc. (ABOS)
is a Buy
Acumen Pharmaceuticals, Inc. Share Price Forecast
-
What is the Acumen Pharmaceuticals, Inc. stock price today?The Acumen Pharmaceuticals, Inc. stock price is 2.57 USD today.
-
Will ABOS stock go up or go down?Acumen Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Acumen Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Acumen Pharmaceuticals, Inc. is not overvalued.
Is Acumen Pharmaceuticals, Inc. Stock a Buy?
-
Acumen Pharmaceuticals, Inc. share price is 2.57 while ABOS 8-day exponential moving average is 2.55, which is a Buy signal.
-
The stock price of ABOS is 2.57 while Acumen Pharmaceuticals, Inc. 20-day EMA is 2.44, which makes it a Buy.
-
Acumen Pharmaceuticals, Inc. 50-day exponential moving average is 2.24 while ABOS share price is 2.57, making it a Buy technically.
-
ABOS stock price is 2.57 and Acumen Pharmaceuticals, Inc. 200-day simple moving average is 1.90, creating a Buy signal.
Fundamental Analysis of Acumen Pharmaceuticals, Inc.
Is Acumen Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.13 per share.
Technical Analysis of Acumen Pharmaceuticals, Inc.
Should I short Acumen Pharmaceuticals, Inc. stock?
-
ABOS Moving Average Covergence Divergence (MACD) indicator is 0.12, suggesting Acumen Pharmaceuticals, Inc. is a Buy
-
Acumen Pharmaceuticals, Inc. Relative Strength Index (RSI) is 56.63, which suggest Acumen Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for Acumen Pharmaceuticals, Inc. is (2.07 - 2.69), which suggest Acumen Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Acumen Pharmaceuticals, Inc. is (1.78 - 2.36), which suggest Acumen Pharmaceuticals, Inc. is a Buy
* Acumen Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.